1. Home
  2. GIB vs ILMN Comparison

GIB vs ILMN Comparison

Compare GIB & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GIB
  • ILMN
  • Stock Information
  • Founded
  • GIB 1976
  • ILMN 1998
  • Country
  • GIB Canada
  • ILMN United States
  • Employees
  • GIB N/A
  • ILMN N/A
  • Industry
  • GIB Professional Services
  • ILMN Medical Specialities
  • Sector
  • GIB Consumer Discretionary
  • ILMN Health Care
  • Exchange
  • GIB Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • GIB 25.5B
  • ILMN 23.6B
  • IPO Year
  • GIB N/A
  • ILMN 2000
  • Fundamental
  • Price
  • GIB $112.53
  • ILMN $143.87
  • Analyst Decision
  • GIB Buy
  • ILMN Buy
  • Analyst Count
  • GIB 3
  • ILMN 19
  • Target Price
  • GIB $136.67
  • ILMN $162.67
  • AVG Volume (30 Days)
  • GIB 158.2K
  • ILMN 2.0M
  • Earning Date
  • GIB 01-29-2025
  • ILMN 02-06-2025
  • Dividend Yield
  • GIB N/A
  • ILMN N/A
  • EPS Growth
  • GIB 6.56
  • ILMN N/A
  • EPS
  • GIB 5.41
  • ILMN N/A
  • Revenue
  • GIB $10,863,578,959.00
  • ILMN $4,390,000,000.00
  • Revenue This Year
  • GIB $8.01
  • ILMN N/A
  • Revenue Next Year
  • GIB $4.21
  • ILMN $4.28
  • P/E Ratio
  • GIB $20.26
  • ILMN N/A
  • Revenue Growth
  • GIB 2.66
  • ILMN N/A
  • 52 Week Low
  • GIB $96.92
  • ILMN $97.36
  • 52 Week High
  • GIB $118.89
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • GIB 49.94
  • ILMN 50.48
  • Support Level
  • GIB $112.19
  • ILMN $140.67
  • Resistance Level
  • GIB $114.95
  • ILMN $151.75
  • Average True Range (ATR)
  • GIB 1.45
  • ILMN 4.76
  • MACD
  • GIB 0.15
  • ILMN 0.47
  • Stochastic Oscillator
  • GIB 44.24
  • ILMN 38.77

About GIB CGI Inc.

CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: